Omada Health, Inc. (OMDA)
Nasdaq · Healthcare · Health Information Services
$20.95+2.85%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $1.3B
- P/E (trailing)
- 87.3
- Forward P/E
- 37.7
- 52-week range
- $10.28 – $26.92
- 52-week change
- −12.58%
- EPS (trailing)
- $0.24
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $260M (+53.24%)
- Net income
- −$12.8M
- Operating margin
- −4.6%
- Diluted EPS
- −$0.35
- Free cash flow
- $16.9M
From the company’s annual report on SEC EDGAR.
About Omada Health, Inc.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Headquarters: South San Francisco, United States · 946 employees · omadahealth.com